Amniotic Fluid and Placental Stem Cells

Dawn M. Delo, Paolo De Coppi, Georg Bartsch, Anthony Atala

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Human amniotic fluid has been used in prenatal diagnosis for more than 70 years. It has proven to be a safe, reliable, and simple screening tool for a wide variety of developmental and genetic diseases. However, there is now evidence that amniotic fluid may have more use than only as a diagnostic tool and may be the source of a powerful therapy for a multitude of congenital and adult disorders. A subset of cells found in amniotic fluid and placenta has been isolated and found to be capable of maintaining prolonged undifferentiated proliferation as well as able to differentiate into multiple tissue types encompassing the three germ layers. It is possible that in the near future, we will see the development of therapies using progenitor cells isolated from amniotic fluid and placenta for the treatment of newborns with congenital malformations as well as of adults, using cryopreserved amniotic fluid and placental stem cells. In this chapter, we describe a number of experiments that have isolated and characterized pluripotent progenitor cells from amniotic fluid and placenta. We also discuss various cell lines derived from amniotic fluid and placenta and future directions for this area of research.

Original languageEnglish
Pages (from-to)426-438
Number of pages13
JournalMethods in Enzymology
Volume419
DOIs
StatePublished - Dec 1 2006

Fingerprint

Amniotic Fluid
Stem cells
Stem Cells
Fluids
Placenta
Germ Layers
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Inborn Genetic Diseases
Prenatal Diagnosis
Screening
Cells
Tissue
Cell Line
Therapeutics
Research
Experiments

ASJC Scopus subject areas

  • Biochemistry

Cite this

Delo, D. M., De Coppi, P., Bartsch, G., & Atala, A. (2006). Amniotic Fluid and Placental Stem Cells. Methods in Enzymology, 419, 426-438. https://doi.org/10.1016/S0076-6879(06)19017-5

Amniotic Fluid and Placental Stem Cells. / Delo, Dawn M.; De Coppi, Paolo; Bartsch, Georg; Atala, Anthony.

In: Methods in Enzymology, Vol. 419, 01.12.2006, p. 426-438.

Research output: Contribution to journalArticle

Delo, DM, De Coppi, P, Bartsch, G & Atala, A 2006, 'Amniotic Fluid and Placental Stem Cells', Methods in Enzymology, vol. 419, pp. 426-438. https://doi.org/10.1016/S0076-6879(06)19017-5
Delo, Dawn M. ; De Coppi, Paolo ; Bartsch, Georg ; Atala, Anthony. / Amniotic Fluid and Placental Stem Cells. In: Methods in Enzymology. 2006 ; Vol. 419. pp. 426-438.
@article{dca9f73e15494e0b95670a1f451b917a,
title = "Amniotic Fluid and Placental Stem Cells",
abstract = "Human amniotic fluid has been used in prenatal diagnosis for more than 70 years. It has proven to be a safe, reliable, and simple screening tool for a wide variety of developmental and genetic diseases. However, there is now evidence that amniotic fluid may have more use than only as a diagnostic tool and may be the source of a powerful therapy for a multitude of congenital and adult disorders. A subset of cells found in amniotic fluid and placenta has been isolated and found to be capable of maintaining prolonged undifferentiated proliferation as well as able to differentiate into multiple tissue types encompassing the three germ layers. It is possible that in the near future, we will see the development of therapies using progenitor cells isolated from amniotic fluid and placenta for the treatment of newborns with congenital malformations as well as of adults, using cryopreserved amniotic fluid and placental stem cells. In this chapter, we describe a number of experiments that have isolated and characterized pluripotent progenitor cells from amniotic fluid and placenta. We also discuss various cell lines derived from amniotic fluid and placenta and future directions for this area of research.",
author = "Delo, {Dawn M.} and {De Coppi}, Paolo and Georg Bartsch and Anthony Atala",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/S0076-6879(06)19017-5",
language = "English",
volume = "419",
pages = "426--438",
journal = "Methods in Enzymology",
issn = "0076-6879",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Amniotic Fluid and Placental Stem Cells

AU - Delo, Dawn M.

AU - De Coppi, Paolo

AU - Bartsch, Georg

AU - Atala, Anthony

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Human amniotic fluid has been used in prenatal diagnosis for more than 70 years. It has proven to be a safe, reliable, and simple screening tool for a wide variety of developmental and genetic diseases. However, there is now evidence that amniotic fluid may have more use than only as a diagnostic tool and may be the source of a powerful therapy for a multitude of congenital and adult disorders. A subset of cells found in amniotic fluid and placenta has been isolated and found to be capable of maintaining prolonged undifferentiated proliferation as well as able to differentiate into multiple tissue types encompassing the three germ layers. It is possible that in the near future, we will see the development of therapies using progenitor cells isolated from amniotic fluid and placenta for the treatment of newborns with congenital malformations as well as of adults, using cryopreserved amniotic fluid and placental stem cells. In this chapter, we describe a number of experiments that have isolated and characterized pluripotent progenitor cells from amniotic fluid and placenta. We also discuss various cell lines derived from amniotic fluid and placenta and future directions for this area of research.

AB - Human amniotic fluid has been used in prenatal diagnosis for more than 70 years. It has proven to be a safe, reliable, and simple screening tool for a wide variety of developmental and genetic diseases. However, there is now evidence that amniotic fluid may have more use than only as a diagnostic tool and may be the source of a powerful therapy for a multitude of congenital and adult disorders. A subset of cells found in amniotic fluid and placenta has been isolated and found to be capable of maintaining prolonged undifferentiated proliferation as well as able to differentiate into multiple tissue types encompassing the three germ layers. It is possible that in the near future, we will see the development of therapies using progenitor cells isolated from amniotic fluid and placenta for the treatment of newborns with congenital malformations as well as of adults, using cryopreserved amniotic fluid and placental stem cells. In this chapter, we describe a number of experiments that have isolated and characterized pluripotent progenitor cells from amniotic fluid and placenta. We also discuss various cell lines derived from amniotic fluid and placenta and future directions for this area of research.

UR - http://www.scopus.com/inward/record.url?scp=33751398387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751398387&partnerID=8YFLogxK

U2 - 10.1016/S0076-6879(06)19017-5

DO - 10.1016/S0076-6879(06)19017-5

M3 - Article

C2 - 17141065

AN - SCOPUS:33751398387

VL - 419

SP - 426

EP - 438

JO - Methods in Enzymology

JF - Methods in Enzymology

SN - 0076-6879

ER -